# A Prospective Observational Study of Effect of Somatropin on Growth Hormone Deficient Adults

> **NCT01088399** · — · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 10673 (actual)

## Conditions studied

- Hypopituitarism
- Pituitary Insufficiency
- Growth Hormone Deficiency, Adult

## Interventions

- **DRUG:** Somatropin (rDNA origin)

## Key facts

- **NCT ID:** NCT01088399
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2002-09
- **Primary completion:** 2012-12
- **Final completion:** 2012-12
- **Target enrollment:** 10673 (ACTUAL)
- **Last updated:** 2014-04-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01088399

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01088399, "A Prospective Observational Study of Effect of Somatropin on Growth Hormone Deficient Adults". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01088399. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*